Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05586178 · ClinicalTrials.gov registry record · NA
Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 177,720
- Enrollment target
NCT05586178: Completed NA study, sponsored by University of California, Los Angeles.
NCT05586178 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 177,720 participants, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (12585% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05586178, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 177,720 participants
- Enrollment target
Study Summary
This study investigates different ways to elevate intentions to get the COVID-19 booster via text-based reminders, including providing information about the booster and leveraging the consistency principle. The proposed randomized controlled trial will examine the impact of these reminders on booster uptake.
Primary Outcome
Whether people receive the bivalent booster at any location reporting to the California Immunization Registry (CAIR)
Interventions
- BEHAVIORAL Reminder that facilitates action
- BEHAVIORAL Consistency framing
- BEHAVIORAL Information provision about the uniqueness of the bivalent booster
- BEHAVIORAL Information provision about bivalent booster eligibility
- BEHAVIORAL Information provision about the severity of COVID-19 symptoms
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177,720 participants |
| Start Date | 2022-10-18 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT05586178 record still lists
NCT05586178 is an interventional study that assigns participants to a tested intervention. Its 177,720 participants enrollment target places it among the larger protocols in the corpus, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (12585% higher).
The record links to 0 conditions, and to 5 interventions - of which Reminder that facilitates action is the first listed.
NCT05586178 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05586178 about?
NCT05586178 is a clinical study titled "Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake". This study investigates different ways to elevate intentions to get the COVID-19 booster via text-based reminders, including providing information about the booster and leveraging the consistency principle. The proposed randomized controlled trial will examine the impact of these reminders on booste...
What is the current status of trial NCT05586178?
This trial is currently completed. It is a NA study. The enrollment target is 177,720 participants. The study started on 2022-10-18. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05586178?
The interventions under investigation include: Reminder that facilitates action (BEHAVIORAL), Consistency framing (BEHAVIORAL), Information provision about the uniqueness of the bivalent booster (BEHAVIORAL), Information provision about bivalent booster eligibility (BEHAVIORAL), Information provision about the severity of COVID-19 symptoms (BEHAVIORAL).
Who is sponsoring clinical trial NCT05586178?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05586178's enrollment target sits among peer trials
177,720 1st of 2000 higher than 2,000 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI